<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">39455984</PMID><DateCompleted><Year>2024</Year><Month>10</Month><Day>26</Day></DateCompleted><DateRevised><Year>2024</Year><Month>10</Month><Day>29</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1471-2458</ISSN><JournalIssue CitedMedium="Internet"><Volume>24</Volume><Issue>1</Issue><PubDate><Year>2024</Year><Month>Oct</Month><Day>25</Day></PubDate></JournalIssue><Title>BMC public health</Title><ISOAbbreviation>BMC Public Health</ISOAbbreviation></Journal><ArticleTitle>Model-based estimates of age-structured SARS-CoV-2 epidemiology in households.</ArticleTitle><Pagination><StartPage>2965</StartPage><MedlinePgn>2965</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">2965</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s12889-024-20308-z</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Understanding how infectious disease transmission varies from person to person, including associations with age and contact behavior, can help design effective control strategies. Within households, transmission may be highly variable because of differing transmission risks by age, household size, and individual contagiousness. Our aim was to disentangle those factors by fitting mathematical models to SARS-CoV-2 household survey and serologic data.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">We surveyed members of 3,381 Utah households from January-April 2021 and performed SARS-CoV-2 antibody testing on all available members. We paired these data with a probabilistic model of household importation and transmission composed of a novel combination of transmission variability and age- and size-structured heterogeneity. We calculated maximum likelihood estimates of mean and variability of household transmission probability between household members in different age groups and different household sizes, simultaneously with importation probability and probabilities of false negative and false positive test results.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">12.8% of individual participants, residing in 17.4% of the participating households, showed serologic evidence of prior infection or reported a prior positive test on the survey. Serologically positive individuals in younger age groups were less likely than older adults to have tested positive during their infection according to our survey results. Our model results suggested that adolescents and young adults (ages 13-24) acquired SARS-CoV-2 infection outside the household at a rate substantially higher than younger children and older adults. Our estimate of the household secondary attack rate (HSAR) among adults aged 45 and older exceeded HSARs to and/or from younger age groups at a given household size. We found lower HSAR in households with more members, independent of age differences. The age-specific HSAR patterns we found could not be explained by age-dependent biological susceptibility and transmissibility alone, suggesting that age groups contacted each other at different rates within households.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">We disentangled several factors contributing to age-specific infection risk, including non-household exposure, within-household exposure to specific age groups, and household size. Within-household contact rate differences played a significant role in driving household transmission epidemiology. These findings provide nuanced insights for understanding community outbreak patterns and mechanisms of differential infection risk.</AbstractText><CopyrightInformation>Â© 2024. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Toth</LastName><ForeName>Damon J A</ForeName><Initials>DJA</Initials><AffiliationInfo><Affiliation>Division of Epidemiology, Department of Internal Medicine, University of Utah School of Medicine, Salt Lake City, UT, United States of America. Damon.Toth@hsc.utah.edu.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Veterans Affairs Salt Lake City Healthcare System, Salt Lake City, UT, United States of America. Damon.Toth@hsc.utah.edu.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Mathematics, University of Utah, Salt Lake City, UT, United States of America. Damon.Toth@hsc.utah.edu.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sheets</LastName><ForeName>Theresa R</ForeName><Initials>TR</Initials><AffiliationInfo><Affiliation>Department of Mathematics, University of Utah, Salt Lake City, UT, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Beams</LastName><ForeName>Alexander B</ForeName><Initials>AB</Initials><AffiliationInfo><Affiliation>Department of Mathematics, University of Utah, Salt Lake City, UT, United States of America.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Present address: Department of Mathematics, Simon Fraser University, Burnaby, BC, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ahmed</LastName><ForeName>Sharia M</ForeName><Initials>SM</Initials><AffiliationInfo><Affiliation>Division of Epidemiology, Department of Internal Medicine, University of Utah School of Medicine, Salt Lake City, UT, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Seegert</LastName><ForeName>Nathan</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Finance, University of Utah David Eccles School of Business, Salt Lake City, UT, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Love</LastName><ForeName>Jay</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Division of Epidemiology, Department of Internal Medicine, University of Utah School of Medicine, Salt Lake City, UT, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Keegan</LastName><ForeName>Lindsay T</ForeName><Initials>LT</Initials><AffiliationInfo><Affiliation>Division of Epidemiology, Department of Internal Medicine, University of Utah School of Medicine, Salt Lake City, UT, United States of America.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Veterans Affairs Salt Lake City Healthcare System, Salt Lake City, UT, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Samore</LastName><ForeName>Matthew H</ForeName><Initials>MH</Initials><AffiliationInfo><Affiliation>Division of Epidemiology, Department of Internal Medicine, University of Utah School of Medicine, Salt Lake City, UT, United States of America.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Veterans Affairs Salt Lake City Healthcare System, Salt Lake City, UT, United States of America.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>75D30121F00003</GrantID><Acronym>CC</Acronym><Agency>CDC HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>75D30121F00003</GrantID><Acronym>CC</Acronym><Agency>CDC HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>75D30121F00003</GrantID><Acronym>CC</Acronym><Agency>CDC HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>75D30121F00003</GrantID><Acronym>CC</Acronym><Agency>CDC HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>75D30121F00003</GrantID><Acronym>CC</Acronym><Agency>CDC HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>75D30121F00003</GrantID><Acronym>CC</Acronym><Agency>CDC HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>75D30121F00003</GrantID><Acronym>CC</Acronym><Agency>CDC HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>AR3473</GrantID><Agency>State of Utah</Agency><Country /></Grant><Grant><GrantID>AR3473</GrantID><Agency>State of Utah</Agency><Country /></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>10</Month><Day>25</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>BMC Public Health</MedlineTA><NlmUniqueID>100968562</NlmUniqueID><ISSNLinking>1471-2458</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000635" MajorTopicYN="N">transmission</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005191" MajorTopicYN="Y">Family Characteristics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014589" MajorTopicYN="N" Type="Geographic">Utah</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002675" MajorTopicYN="N">Child, Preschool</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="Y">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000367" MajorTopicYN="N">Age Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007223" MajorTopicYN="N">Infant</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015233" MajorTopicYN="N">Models, Statistical</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008962" MajorTopicYN="N">Models, Theoretical</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Age-structure</Keyword><Keyword MajorTopicYN="N">Household</Keyword><Keyword MajorTopicYN="N">Infection risk</Keyword><Keyword MajorTopicYN="N">Mathematical model</Keyword><Keyword MajorTopicYN="N">Parameter estimation</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword><Keyword MajorTopicYN="N">Serology</Keyword><Keyword MajorTopicYN="N">Transmission</Keyword></KeywordList><CoiStatement>D.T. reports receiving grants from Pfizer, Inc. A.B. reports receiving graduate student funding from bioMÃ©rieux. All other authors declare that they have no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>5</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>10</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>26</Day><Hour>19</Hour><Minute>27</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>26</Day><Hour>19</Hour><Minute>26</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>25</Day><Hour>23</Hour><Minute>57</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>10</Month><Day>25</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39455984</ArticleId><ArticleId IdType="doi">10.1186/s12889-024-20308-z</ArticleId><ArticleId IdType="pii">10.1186/s12889-024-20308-z</ArticleId><ArticleId IdType="pmc">PMC11515260</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Lloyd-Smith JO, Schreiber SJ, Kopp PE, Getz WM. Superspreading and the effect of individual variation on disease emergence. Nature. 2005;438(7066):355â9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7094981</ArticleId><ArticleId IdType="pubmed">16292310</ArticleId></ArticleIdList></Reference><Reference><Citation>VanderWaal KL, Ezenwa VO. Heterogeneity in pathogen transmission: mechanisms and methodology. Funct Ecol. 2016;30(10):1606â22.</Citation></Reference><Reference><Citation>Pellis L, Cauchemez S, Ferguson NM, Fraser C. Systematic selection between age and household structure for models aimed at emerging epidemic predictions. Nat Commun. 2020;11(1):906.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7021781</ArticleId><ArticleId IdType="pubmed">32060265</ArticleId></ArticleIdList></Reference><Reference><Citation>Buckee C, Noor A, Sattenspiel L. Thinking clearly about social aspects of infectious disease transmission. Nature. 2021;595(7866):205â13.</Citation><ArticleIdList><ArticleId IdType="pubmed">34194045</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma KC, Menkir TF, Kissler S, Grad YH, Lipsitch M. Modeling the impact of racial and ethnic disparities on COVID-19 epidemic dynamics. Elife. 2021;10:10.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8221808</ArticleId><ArticleId IdType="pubmed">34003112</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferguson NM, Donnelly CA, Anderson RM. Transmission dynamics and epidemiology of dengue: insights from age-stratified sero-prevalence surveys. Philos Trans R Soc Lond B Biol Sci. 1999;354(1384):757â68.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1692557</ArticleId><ArticleId IdType="pubmed">10365401</ArticleId></ArticleIdList></Reference><Reference><Citation>Meyerowitz EA, Richterman A, Gandhi RT, Sax PE. Transmission of SARS-CoV-2: a review of viral, host, and environmental factors. Ann Intern Med. 2021;174(1):69â79.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7505025</ArticleId><ArticleId IdType="pubmed">32941052</ArticleId></ArticleIdList></Reference><Reference><Citation>Qian H, Miao T, Liu L, Zheng X, Luo D, Li Y. Indoor transmission of SARS-CoV-2. Indoor Air. 2021;31(3):639â45. 10.1111/ina.12766.</Citation><ArticleIdList><ArticleId IdType="pubmed">33131151</ArticleId></ArticleIdList></Reference><Reference><Citation>Yonker LM, Neilan AM, Bartsch Y, Patel AB, Regan J, Arya P, et al. Pediatric severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): clinical presentation, infectivity, and Immune responses. J Pediatr. 2020;227:45â52.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7438214</ArticleId><ArticleId IdType="pubmed">32827525</ArticleId></ArticleIdList></Reference><Reference><Citation>Ghosh AK, Venkatraman S, Soroka O, Reshetnyak E, Rajan M, An A, et al. Association between overcrowded households, multigenerational households, and COVID-19: a cohort study. Public Health. 2021;198:273â9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8328572</ArticleId><ArticleId IdType="pubmed">34492508</ArticleId></ArticleIdList></Reference><Reference><Citation>Hart WS, Abbott S, Endo A, Hellewell J, Miller E, Andrews N, et al. Inference of the SARS-CoV-2 generation time using UK household data. Elife. 2022;11:11.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8967386</ArticleId><ArticleId IdType="pubmed">35138250</ArticleId></ArticleIdList></Reference><Reference><Citation>Endo A, Uchida M, Kucharski AJ, Funk S. Fine-scale family structure shapes influenza transmission risk in households: insights from primary schools in Matsumoto city, 2014/15. PLoS Comput Biol. 2019;15(12):e1007589.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6959609</ArticleId><ArticleId IdType="pubmed">31877122</ArticleId></ArticleIdList></Reference><Reference><Citation>Cauchemez S, Carrat F, Viboud C, Valleron AJ, Boelle PY. A bayesian MCMC approach to study transmission of influenza: application to household longitudinal data. Stat Med. 2004;23(22):3469â87.</Citation><ArticleIdList><ArticleId IdType="pubmed">15505892</ArticleId></ArticleIdList></Reference><Reference><Citation>Bubar KM, Reinholt K, Kissler SM, Lipsitch M, Cobey S, Grad YH, et al. Model-informed COVID-19 vaccine prioritization strategies by age and serostatus. Science. 2021;371(6532):916â21.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7963218</ArticleId><ArticleId IdType="pubmed">33479118</ArticleId></ArticleIdList></Reference><Reference><Citation>Metcalf CJ, Farrar J, Cutts FT, Basta NE, Graham AL, Lessler J, et al. Use of serological surveys to generate key insights into the changing global landscape of infectious disease. Lancet. 2016;388(10045):728â30.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5678936</ArticleId><ArticleId IdType="pubmed">27059886</ArticleId></ArticleIdList></Reference><Reference><Citation>Longini I, Koopman JS. Household and community transmission parameters from final distributions of infections in households. Biometrics. 1982;38(1):115â26.</Citation><ArticleIdList><ArticleId IdType="pubmed">7082755</ArticleId></ArticleIdList></Reference><Reference><Citation>Bi Q, Lessler J, Eckerle I, Lauer SA, Kaiser L, Vuilleumier N, et al. Insights into household transmission of SARS-CoV-2 from a population-based serological survey. Nat Commun. 2021;12(1):3643.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8206123</ArticleId><ArticleId IdType="pubmed">34131124</ArticleId></ArticleIdList></Reference><Reference><Citation>Toth DJA, Beams AB, Keegan LT, Zhang Y, Greene T, Orleans B, et al. High variability in transmission of SARS-CoV-2 within households and implications for control. PLoS ONE. 2021;16(11):e0259097.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8580228</ArticleId><ArticleId IdType="pubmed">34758042</ArticleId></ArticleIdList></Reference><Reference><Citation>Utah health and economic recovery outreach home - Utah hero. 2021. Available from: https://eccles.utah.edu/utah-hero/.</Citation></Reference><Reference><Citation>Samore MH, Looney A, Orleans B, Greene T, Seegert N, Delgado JC, et al. Probability-based estimates of severe acute respiratory syndrome coronavirus 2 seroprevalence and detection fraction, Utah, USA. Emerg Infect Dis. 2021;27(11):2786â94.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8544980</ArticleId><ArticleId IdType="pubmed">34469285</ArticleId></ArticleIdList></Reference><Reference><Citation>Hershow RB, Wu K, Lewis NM, Milne AT, Currie D, Smith AR, et al. Low SARS-CoV-2 transmission in elementary schools - Salt Lake County, Utah, December 3, 2020-January 31, 2021. MMWR Morb Mortal Wkly Rep. 2021;70(12):442â8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7993560</ArticleId><ArticleId IdType="pubmed">33764967</ArticleId></ArticleIdList></Reference><Reference><Citation>Anti-SARS-CoV-2 ELISA (IgG) - instructions for use. 2022. Available from: https://www.fda.gov/media/137609/download.</Citation></Reference><Reference><Citation>SARS-CoV-2 IgG architect - instructions for use. 2020. Available from: https://www.fda.gov/media/137383/download.</Citation></Reference><Reference><Citation>Dimension vista SARS-CoV-2 IgG (COV2G) - instructions for use. Available from: https://www.fda.gov/media/145020/download.</Citation></Reference><Reference><Citation>Tang MS, Hock KG, Logsdon NM, Hayes JE, Gronowski AM, Anderson NW, et al. Clinical performance of two SARS-CoV-2 Serologic assays. Clin Chem. 2020;66(8):1055â62.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7239232</ArticleId><ArticleId IdType="pubmed">32402061</ArticleId></ArticleIdList></Reference><Reference><Citation>Rychert J, Couturier MR, Elgort M, Lozier BK, Laâulu S, Genzen JR, et al. Evaluation of 3 SARS-CoV-2 IgG antibody assays and correlation with neutralizing antibodies. J Appl Lab Med. 2021;6(3):614â24.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7665531</ArticleId><ArticleId IdType="pubmed">33064790</ArticleId></ArticleIdList></Reference><Reference><Citation>Demmer RT, Baumgartner B, Wiggen TD, Ulrich AK, Strickland AJ, Naumchik BM, et al. Identification of natural SARS-CoV-2 infection in seroprevalence studies among vaccinated populations. Mayo Clin Proc. 2022;97(4):754â60.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8841164</ArticleId><ArticleId IdType="pubmed">35379422</ArticleId></ArticleIdList></Reference><Reference><Citation>Age Groups - MeSH - NCBI. 2023.Â Available from:Â https://www.ncbi.nlm.nih.gov/mesh/68009273.</Citation></Reference><Reference><Citation>Cronin CJ, Evans WN. Nursing home quality, COVID-19 deaths, and excess mortality. J Health Econ. 2022;82:102592.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8776351</ArticleId><ArticleId IdType="pubmed">35104669</ArticleId></ArticleIdList></Reference><Reference><Citation>Paul LA, Daneman N, Schwartz KL, Science M, Brown KA, Whelan M, et al. Association of age and pediatric household transmission of SARS-CoV-2 infection. JAMA Pediatr. 2021;175(11):1151â8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8369380</ArticleId><ArticleId IdType="pubmed">34398179</ArticleId></ArticleIdList></Reference><Reference><Citation>Bansal S, Grenfell BT, Meyers LA. When individual behaviour matters: homogeneous and network models in epidemiology. J R Soc Interface. 2007;4(16):879â91.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2394553</ArticleId><ArticleId IdType="pubmed">17640863</ArticleId></ArticleIdList></Reference><Reference><Citation>Wegehaupt O, Endo A, Vassall A. Superspreading, overdispersion and their implications in the SARS-CoV-2 (COVID-19) pandemic: a systematic review and meta-analysis of the literature. BMC Public Health. 2023;23(1):1003.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10227392</ArticleId><ArticleId IdType="pubmed">37254143</ArticleId></ArticleIdList></Reference><Reference><Citation>Ke R, Martinez PP, Smith RL, Gibson LL, Mirza A, Conte M, et al. Daily longitudinal sampling of SARS-CoV-2 infection reveals substantial heterogeneity in infectiousness. Nat Microbiol. 2022;7(5):640â52.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9084242</ArticleId><ArticleId IdType="pubmed">35484231</ArticleId></ArticleIdList></Reference><Reference><Citation>Davies NG, Klepac P, Liu Y, Prem K, Jit M, group CC-w, et al. Age-dependent effects in the transmission and control of COVID-19 epidemics. Nat Med. 2020;26(8):1205â11.</Citation><ArticleIdList><ArticleId IdType="pubmed">32546824</ArticleId></ArticleIdList></Reference><Reference><Citation>Keegan LT, Truelove S, Lessler J. Analysis of vaccine effectiveness against COVID-19 and the emergence of Delta and other variants of concern in Utah. JAMA Netw Open. 2021;4(12):e2140906.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8703247</ArticleId><ArticleId IdType="pubmed">34940869</ArticleId></ArticleIdList></Reference><Reference><Citation>Madewell ZJ, Yang Y, Longini IM Jr, Halloran ME, Dean NE. Household secondary attack rates of SARS-CoV-2 by variant and vaccination status: an updated systematic review and meta-analysis. JAMA Netw Open. 2022;5(4):e229317.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9051991</ArticleId><ArticleId IdType="pubmed">35482308</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>